Abstract:Considerable evidence is mounting that dyshomeostasis of the redox-active biometals, Cu and Fe, and oxidative stress contribute to the neuropathology of Alzheimer's disease (AD). Present data suggest that metals can interact directly with Abeta peptide, the principal component of beta-amyloid that is one of the primary lesions in AD. The binding of metals to Abeta modulates several physiochemical properties of Abeta that are thought to be central to the pathogenicity of the peptide. First, We and others have shown that metals can promote the in vitro aggregation into tinctorial Abeta amyloid. Studies have confirmed that insoluble amyloid plaques in postmortem AD brain are abnormally enriched in Cu, Fe, and Zn. Conversely, metal chelators dissolve these proteinaceous deposits from postmortem AD brain tissue and attenuate cerebral Abeta amyloid burden in APP transgenic mouse models of AD. Second, we have demonstrated that redox-active Cu(II) and, to a lesser extent, Fe(III) are reduced in the presence of Abeta with concomitant production of reactive oxygen species (ROS), hydrogen peroxide (H2O2) and hydroxyl radical (OH.). These Abeta/metal redox reactions, which are silenced by redox-inert Zn(II), but exacerbated by biological reducing agents, may lead directly to the widespread oxidation damages observed in AD brains. Moreover, studies have also shown that H2O2 mediates Abeta cellular toxicity and increases the production of both Abeta and amyloid precursor protein (APP). Third, the 5' untranslated region (5'UTR) of APP mRNA has a functional iron-response element (IRE), which is consistent with biochemical evidence that APP is a redox-active metalloprotein. Hence, the redox interactions between Abeta, APP, and metals may be at the heart of a pathological positive feedback system wherein Abeta amyloidosis and oxidative stress promote each other. The emergence of redox-active metals as key players in AD pathogenesis strongly argues that amyloid-specific metal-complexing agents and antioxidants be investigated as possible disease-modifying agents for treating this horrible disease.

Zinc and its effects on oxidative stress in Alzheimer’s disease

Oxidative Stress Markers and Metal Ions Are Correlated with Cognitive Function in Alzheimer’s Disease

Brain Zinc Metabolism and Alzheimer's Disease

Multifunctional roles of zinc in Alzheimer’s disease

Disruption of Brain Zinc Homeostasis Promotes the Pathophysiological Progress of Alzheimer's Disease.

Zinc Transporters in Alzheimer’s Disease

Alzheimer's disease, beta-amyloid protein and zinc.

Oxidative stress and the pathogenesis of Alzheimer's disease.

Molecular mechanism of zinc neurotoxicity in Alzheimer’s disease

Alzheimer Disease: Recent Updates on Apolipoprotein E and Gut Microbiome Mediation of Oxidative Stress, and Prospective Interventional Agents.

Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease

Disturbance of iron metabolism in brain and Alzheimer's disease

Redox-active metals, oxidative stress, and Alzheimer's disease pathology.

Metal Ions Influx is A Double Edged Sword for the Pathogenesis of Alzheimer'S Disease

Brain, aging and neurodegeneration: Role of zinc ion availability

Targeting Zincosomes to Unveil Lysosomal Zinc ion Dynamics and Their Role in Exacerbating Alzheimer's Pathology

Metals homeostasis and related proteins in alzheimer's disease

Current understanding of metal ions in the pathogenesis of Alzheimer’s disease

Natural Antioxidants in Prevention and Management of Alzheimer's Disease.

Free radicals in Alzheimer's disease: From pathophysiology to clinical trial results

Inflammation, genes and zinc in Alzheimer's disease